Abumayyaleh, M.; Pilsinger, C.; El-Battrawy, I.; Kummer, M.; Kuschyk, J.; Borggrefe, M.; Mügge, A.; Aweimer, A.; Akin, I.
Clinical Outcomes in Patients with Ischemic versus Non-Ischemic Cardiomyopathy after Angiotensin-Neprilysin Inhibition Therapy. J. Clin. Med. 2021, 10, 4989.
https://doi.org/10.3390/jcm10214989
AMA Style
Abumayyaleh M, Pilsinger C, El-Battrawy I, Kummer M, Kuschyk J, Borggrefe M, Mügge A, Aweimer A, Akin I.
Clinical Outcomes in Patients with Ischemic versus Non-Ischemic Cardiomyopathy after Angiotensin-Neprilysin Inhibition Therapy. Journal of Clinical Medicine. 2021; 10(21):4989.
https://doi.org/10.3390/jcm10214989
Chicago/Turabian Style
Abumayyaleh, Mohammad, Christina Pilsinger, Ibrahim El-Battrawy, Marvin Kummer, Jürgen Kuschyk, Martin Borggrefe, Andreas Mügge, Assem Aweimer, and Ibrahim Akin.
2021. "Clinical Outcomes in Patients with Ischemic versus Non-Ischemic Cardiomyopathy after Angiotensin-Neprilysin Inhibition Therapy" Journal of Clinical Medicine 10, no. 21: 4989.
https://doi.org/10.3390/jcm10214989
APA Style
Abumayyaleh, M., Pilsinger, C., El-Battrawy, I., Kummer, M., Kuschyk, J., Borggrefe, M., Mügge, A., Aweimer, A., & Akin, I.
(2021). Clinical Outcomes in Patients with Ischemic versus Non-Ischemic Cardiomyopathy after Angiotensin-Neprilysin Inhibition Therapy. Journal of Clinical Medicine, 10(21), 4989.
https://doi.org/10.3390/jcm10214989
